Indrayani Biotech Announces Rights Issue Terms for Partly Paid-Up Equity Shares
Indrayani Biotech Ltd announced key details regarding its upcoming Rights Issue following a meeting of the Rights Issue Committee held on Thursday, 09 April 2026. The committee approved the terms for the issuance of partly paid-up equity shares.The rights issue proposes the issuance of 3,25,25,897 equity shares of the Company, each on a partly paid-up basis, for an aggregate amount up to ₹ 49.90 crore. The rights issue price is set at ₹ 15 per Rights Equity Share when fully paid up, which includes a premium of ₹ 5 per Rights Equity Share.
Payment structure for the rights shares is detailed as follows:
| Amount payable per right equity shares | Face Value (Rs.) | Premium (Rs.) | Total Amount (Rs.) |
|---|---|---|---|
| On application | 2.5 | 1.25 | 3.75 |
| On or one more additional Calls with terms and conditions such as the number of Calls and timing and quantum of each Calls as may be decided by the Rights Issue committee from time to time | 7.5 | 3.75 | 11.25 |
| Total (Rs.) | 10 | 5 | 15 |
The record date for the rights issue has been set as Tuesday, 28 April 2026. The timeline for the rights issue period includes several key dates:
- Rights Issue Opening Date: Wednesday, 27 May 2026
- On-market renunciation period: Wednesday, 27 May 2026 to Tuesday, 16 June 2026
- Rights Issue Closing Date: Thursday, 25 June 2026
The document also specified that eligible equity shareholders must ensure off-market renunciation is completed so that rights entitlements are credited to the demat account of the renouncees on or before the Issue closing date.
Outstanding Equity Shares and Entitlement Ratio
The outstanding equity shares figures provided are:- Prior to Rights Issue: 4,55,36,256 equity shares
- Post Rights Issue: 7,80,62,153 equity shares (assuming full subscription and payment of call monies)
The rights entitlement ratio is set at 5 Rights Equity Shares for every 7 fully paid-up equity shares of the Company held by the eligible equity shareholders as on the record date.
For the process, the company noted that arrangements have been made with NSDL and CDSL for the credits of the rights entitlements with a separate ISIN in dematerialized form to the demat account of eligible equity shareholders as on the Record Date. The meeting of the Right Issue Committee commenced at 5:50 PM IST and concluded at 7:15 PM IST.
Stock Price Movement
Thursday saw Indrayani Biotech Ltd settle at ₹10.89, climbing 6.76% in after-hours trading. The shares fluctuated throughout the day, ultimately trading within a range spanning from ₹10.20 to ₹11.30.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.